CD123 is a cell surface receptor that transmits signal from the cytokine interleukin 3 and has been identified as a possible target in the treatment of acute myeloid leukemia.22,23 The library was chosen for analysis because the generation of antibodies using standard clone selection and expression had yielded few unique hits. Here, CD177 is linked to acute myeloid leukemia.